Senetek PLC (OTC Bulletin Board: SNTKY), a life sciences product development company targeting the science of aging, nowadays reported that Plethora Solutions Holdings PLC (AIM: PLE), Senetek’s
exclusive licensee for its patented erectile dysfunction drug Invicorp(R) in North America, has an [click link for full article]
Original post by Richard Sogn, MD
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.